Clinical Trials Logo

Clinical Trial Summary

. This study aimed to determine and compare the effect of vaginal sildenafil citrate and estradiol valerate on endometrial thickness, blood flow and pregnancy rates in infertile women.


Clinical Trial Description

The study is a randomized controlled trial that was carried on 148 infertile women with unexplained infertility. Patients were divided into 3 groups. Group 1 included 48 patients who received oral estradiol valerate (Cyclo-Progynova 2mg, from day 8th till triggering of ovulation), another 50 patients in group 2 received oral Sildenafil (Respatio 20mg/12hr film coated tablets for 5 days starting from last day of menstruation till ovulation), while group 3 was the control one who included 50 patients were given ovulation induction with CC 50mg/12hr from 2nd to 7th day of cycle. Every patient underwent a transvaginal ultrasound to determine ovulation, number of follicles, and pregnancy rates. Miscarriage, ectopic pregnancy, and multiple pregnancies were tracked for 3 months, as were any adverse consequences. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05753098
Study type Interventional
Source Beni-Suef University
Contact
Status Completed
Phase Phase 4
Start date January 15, 2021
Completion date January 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT03881904 - OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol Phase 1/Phase 2
Recruiting NCT05677269 - The (Cost-)Effectiveness of Surgical Excision of Colorectal Endometriosis Compared to ART Treatment Trajectory
Not yet recruiting NCT02940535 - Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response N/A
Recruiting NCT05211583 - Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women
Completed NCT05137964 - A Cross Sectional Evaluation of Vitamin D Status and Ovarian Reserve Markers